|1.||Jick, Susan S: 11 articles (09/2015 - 03/2008)|
|2.||Meier, Christoph R: 11 articles (09/2015 - 03/2008)|
|3.||Bodmer, Michael: 9 articles (09/2015 - 06/2010)|
|4.||Maffioli, Pamela: 8 articles (04/2014 - 08/2009)|
|5.||Derosa, Giuseppe: 8 articles (04/2014 - 08/2009)|
|6.||Becker, Claudia: 6 articles (01/2015 - 11/2011)|
|7.||Cicero, Arrigo F G: 6 articles (10/2011 - 08/2009)|
|8.||Ferrari, Ilaria: 6 articles (10/2011 - 08/2009)|
|9.||D'Angelo, Angela: 6 articles (10/2011 - 08/2009)|
|10.||Palumbo, Ilaria: 6 articles (10/2011 - 08/2009)|
|1.||Type 2 Diabetes Mellitus (MODY)
07/01/1998 - "These new medications, safer and sometimes effective in a single daily administration, represent an alternative to classic oral antidiabetic agents allowing therapeutic combinations and a more global management of NIDDM."
09/01/2010 - "Many plant-based products have been suggested as potential antidiabetic agents, but few have been shown to be effective in treating the symptoms of Type 2 diabetes mellitus (T2DM) in human studies, and little is known of their mechanisms of action. "
05/01/2002 - "In the last few years there has been an explosion of research that has improved our understanding of the pathogenesis of Type 2 diabetes mellitus (DM-2) and has led to the development of new oral antidiabetic drugs. "
01/01/2012 - "The objective of this study was to examine whether a simple, brief integrated approach to depression and type 2 diabetes mellitus (type 2 diabetes) treatment improved adherence to oral hypoglycemic agents and antidepressant medications, glycemic control, and depression among primary care patients. "
05/01/2015 - "To assess the safety and efficacy of long-term administration of teneligliptin alone and in combination with oral antidiabetic drugs in Japanese type 2 diabetes mellitus (T2DM) patients with insufficient glycemic control. "
07/01/1999 - "Indeed, patients taking oral sulfonylurea hypoglycemic agents (i.e., KATP channel inhibitors) for treatment of diabetes mellitus are resistant to the otherwise profoundly protective effects of IPC. "
11/01/2008 - "As such, long-term studies and studies with cardiovascular end-points are needed to confirm the true benefits of these new classes of antidiabetic drugs in the treatment of diabetes mellitus."
10/01/2006 - "The present study was designed to investigate clinically the hypoglycemic effect of seeds of Azadirachta indica in Type-2 diabetes mellitus. "
01/01/2005 - "We are awaiting the results of multiple endpoint studies with newer antidiabetic drugs which may change our current concept of management of diabetes mellitus in these patients in the near future."
03/01/1990 - "The results of this study showed that: 1. Seventy five per cent of patients with diabetes mellitus control their disease with antidiabetic drugs. "
09/01/2010 - "The complementary mechanism of action of DPP-4 inhibitors with other oral antidiabetic drugs affords clinicians an effective and well-tolerated treatment option for early and more aggressive management of hyperglycemia in patients with type 2 diabetes."
04/01/2007 - "The DPP-4 inhibitors, which can be used as monotherapy or in combination with other antidiabetic drugs, are a promising new treatment option, especially for patients with early-stage T2DM and more severe hyperglycemia."
05/01/2010 - "Despite the role played by hyperglycemia in the pathogenesis of cardiovascular events, studies showing an improvement of cardiovascular outcomes by anti-hyperglycemic or hypoglycemic agents are not conclusive. "
03/20/2014 - "The group of recently diagnosed patients (<3 months, symptomatic severe hyperglycemia, D-group) were younger (57.1 [10.8] vs 64.2 [12.1] years; P<.01) and had a higher starting HbA1c (12.1 [1.8] vs 10.5 [2.5] %; P<.001) than patients included in the program for oral antidiabetic drugs' failure (F-group). "
01/01/2013 - "Our results illustrated that these food grade herbs are potent natural hypoglycemic agents and can be used as active ingredients for low glycemic index food production or TCM herbal formulations for controlling hyperglycemia."
01/01/2009 - "[Could oral antidiabetic agents be useful in the management of different types of diabetes and syndromes of insulin resistance in children and adolescents?]."
08/01/2009 - "Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study."
05/01/2009 - "The present study was designed to further confirm the hypoglycemic effect of APS and to investigate its possible mechanism underlying the improvement of insulin resistance in vivo and in vitro. "
05/01/2005 - "To study the long term cardiovascular effects of oral antidiabetic agents in non-diabetic patients with insulin resistance. "
05/01/2005 - "Long term cardiovascular effects of oral antidiabetic agents in non-diabetic patients with insulin resistance: double blind, prospective, randomised study."
|5.||Weight Loss (Weight Reduction)
09/01/2009 - "Lifestyle interventions aimed at weight loss and increased physical activity and therapy with antidiabetic drugs have proven effective in reducing the risk of new-onset diabetes in high-risk individuals. "
07/01/2008 - "Primary prevention studies have demonstrated that intensive exercise and weight reduction, and to a lesser extent certain antidiabetic agents, can reduce new onset diabetes in at-risk individuals. "
02/01/2015 - "Effects of selected antidiabetics on weight loss--a retrospective database analysis."
01/01/2015 - "Network meta-analysis found that EX10BID, LIR1.8QD, and EX2QW obtained a higher proportion of patients with weight loss than other traditional hypoglycemic agents. "
05/01/2013 - "In this article, lifestyle intervention strategies and current antidiabetic agents are evaluated for their efficacy, safety, and weight-loss potential. "
|4.||glargine (insulin glargine)
|8.||Blood Glucose (Blood Sugar)
|1.||Transplantation (Transplant Recipients)
|4.||Diet Therapy (Therapy, Diet)